Bleeder Medicine/Drugs-Buy Kentucky Red-Lasix/Salix-Frusemide-Furosemide
Perhaps the most widely recognized of all problems affecting racehorses is "bleeding," or exercise-induced pulmonary hemorrhage (EIPH). EIPH is bleeding within the lungs that occurs as a result of the maximal effort of horses during exercise. The anatomy of the horse's lungs, combined with its remarkable athletic ability, can result in the rupture of small capillaries and the leakage of blood into the airway. Most equine athletes bleed at some time during their careers and many racehorses might bleed every time they undertake intense exercise.
We also know that bleeding can occur in situations other than flat racing. For example, EIPH has been detected in steeplechasers, three-day eventers and polo ponies, among others. Bleeding has even been observed in draft horses pulling heavy loads.
EIPH has been recognized for more than 300 years but we still have more questions than answers when it comes to preventing this problem. Research in the last 20 or so years has shed some light on why horses bleed during strenuous exercise. How to treat and prevent bleeding is no less contentious, in large part because of controversy concerning the potential performance-enhancing effects of furosemide (frusemide also known as Salix), the drug administered to racehorses with a history of bleeding.
Furosemide is the primary treatment for the disorder, but no treatment has been shown to totally eliminate EIPH. The drug furosemide is widely used in the horse racing industry in North America but is banned on race days in other countries. More than 90% of racing Thoroughbreds and 50% of racing Standarbreds in the United States and Canada are given furosemide a few hours before racing to prevent bleeding.
Other medicines used to prevent bleeding are Aminocaproic acid (Amicar), conjugated estrogens, Tranexamic acid, and lastly, Carbazochrome.
Carbazochrome is used for the systemic control of capillary bleeding associated with increased capillary permeability. In the form Carbazochrome Salicylate, it is known as Kentucky Red. It is reportedly used in horses to treat certain respiratory problems such as Exercise-Induced Pulmonary Hemorrhaging (E.I.P.H).
Amicar is a fibrinolysis inhibitor, designed to inhibit the breakdown of blood clots. In early equine studies of the drug, researchers found that Amicar enhanced clot maintenance and stability. While this research indicated that Amicar might help some horses, it did not assess the drug’s effects on EIPH. |
|
